Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin Lymphoma
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01569204 |
|
Recruitment Status :
Completed
First Posted : April 3, 2012
Last Update Posted : October 29, 2018
|
Sponsor:
University of Cologne
Information provided by (Responsible Party):
Prof. Dr. Peter Borchmann, University of Cologne
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | March 2014 |
| Actual Study Completion Date : | December 2017 |